Changchun, Jilin, China Changchun BCHT Biotechnology appeared to be the Corporate Investor, which was created in 2004. The fund was located in Asia if to be more exact in China. The leading representative office of defined Corporate Investor is situated in the Changchun.
Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Mucosis. For fund there is no match between the location of its establishment and the land of its numerous investments - The Netherlands. We can highlight the next thriving fund investment areas, such as Health Care, Medical.
The typical case for the fund is to invest in rounds with 5 participants. Despite the Changchun BCHT Biotechnology, startups are often financed by NV NOM, MedSciences Capital, BioGeneration Ventures. The meaningful sponsors for the fund in investment in the same round are Utrecht Holdings, NV NOM, MedSciences Capital. In the next rounds fund is usually obtained by Wellcome Trust, BioGeneration Ventures.
The fund is constantly included in less than 2 deals per year. The common things for fund are deals in the range of 5 - 10 millions dollars. The important activity for fund was in 2014.
Related Funds
| Fund Name | Location |
| a2b SGPS | - |
| Dongyang Wenhan | China, Jinhua, Zhejiang |
| DXC Technology | Arlington, United States, Virginia |
| Houxing Capital | - |
| Leclerc family | - |
| Linhao Touzi | China, Shanghai |
| Rihe Keji | Beijing, China, Haidian |
| Shenqiankun Touzi | China, Guangdong, Shenzhen |
| Woodstock | - |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data 